AUNA.NYSEAuna SA

SCHEDULE: AUNA S.A. Major Shareholder Reduces Stake by 19.5%

Sentiment:

Amendment to Schedule 13D


📋All filings for Auna SA

Grupo Angeles Servicios de Salud and affiliates have reduced their beneficial ownership in AUNA S.A. Class A Ordinary Shares to 19.50% through recent sales.

Worse than expectedA significant shareholder, Grupo Angeles Servicios de Salud, has reduced its stake in AUNA S.A. by selling 476,659 Class A Ordinary Shares.The sales occurred at progressively lower prices, from $4.99 to $4.61 per share, which can be interpreted as a negative signal regarding the shareholder's confidence in the company's short-term prospects or valuation.

Summary

  • Grupo Angeles Servicios de Salud, S.A. de C.V. (GASS), along with Grupo Vazol, S.A. de C.V., Corpvaza, S.A. de C.V., and Mr. Olegario Vazquez Aldir (collectively, the "Reporting Persons"), filed Amendment No. 5 to their Schedule 13D.
  • Between the filing of Amendment No. 4 and January 15, 2026, GASS sold a total of 476,659 Class A Ordinary Shares.
  • The total selling price for these shares amounted to USD$2,282,493.00.
  • Following these transactions, the Reporting Persons beneficially own 5,869,747 Class A Ordinary Shares.
  • This ownership represents approximately 19.50% of the total outstanding Class A Ordinary Shares, based on 30,095,388 shares outstanding as of June 30, 2025.
  • The sales occurred on the New York Stock Exchange with prices ranging from $4.61 to $4.99 per share.

Sentiment

Score: 3

Explanation: The sentiment is negative due to a significant insider selling activity by a major shareholder, especially given the declining share prices during the sale period. This often signals a lack of confidence or a strategic divestment that could put downward pressure on the stock.

Negatives

  • A significant shareholder, Grupo Angeles Servicios de Salud, has reduced its stake by selling 476,659 Class A Ordinary Shares.
  • The sales occurred at declining prices, from $4.99 per share down to $4.61 per share, potentially indicating a negative sentiment or selling pressure.

Future Outlook

NA

Industry Context

This filing primarily concerns a change in beneficial ownership by a major shareholder and does not provide specific details on broader industry trends or competitive landscape for AUNA S.A., which operates in the healthcare sector.

Stakeholder Impact

  • Shareholders: The reduction in stake by a major shareholder could be perceived negatively, potentially leading to decreased investor confidence and downward pressure on the share price.
  • Market Perception: The market may interpret this insider selling as a signal of reduced optimism from a knowledgeable party, affecting overall sentiment towards AUNA S.A.

Key Dates

DateDescription
2024-04-12Date of power of attorney for Mr. Vazquez Aldir's signature, previously filed with SEC as an exhibit to a Schedule 13G.
2024-08-22Original Schedule 13D filing date by the Reporting Persons.
2024-09-12Amendment No. 1 to Schedule 13D filed.
2025-01-14Amendment No. 2 to Schedule 13D filed.
2025-06-30Assumed date for 30,095,388 Class A Ordinary Shares outstanding, as reported in Form 6-K/A.
2025-10-28Date Issuer furnished Form 6-K/A to the SEC, reporting outstanding shares.
2025-11-13Amendment No. 3 to Schedule 13D filed.
2025-12-02Amendment No. 4 to Schedule 13D filed.
2025-12-04GASS sold 15,216 Class A Ordinary Shares at $4.99.
2025-12-05GASS sold 99,570 Class A Ordinary Shares at $4.99.
2026-01-09GASS sold 59,040 Class A Ordinary Shares at a weighted average price of $4.86.
2026-01-12GASS sold 84,301 Class A Ordinary Shares at a weighted average price of $4.81.
2026-01-13Date of event requiring filing of this statement; GASS sold 73,221 Class A Ordinary Shares at a weighted average price of $4.70.
2026-01-14GASS sold 49,245 Class A Ordinary Shares at a weighted average price of $4.69.
2026-01-15GASS sold 96,066 Class A Ordinary Shares at a weighted average price of $4.61; Date of filing of Amendment No. 5.

Recommendation

hold

While a significant insider sale is a negative signal, the filing itself does not provide enough fundamental information to warrant a 'sell' recommendation without further analysis of AUNA S.A.'s financial health and strategic direction. Investors should 'hold' with caution, closely monitoring future filings, company performance, and any further insider transactions, as this sale could indicate underlying concerns or simply a portfolio rebalancing by the reporting persons.

Keywords

AUNA S.A., Class A Ordinary Shares, Schedule 13D Amendment, Beneficial Ownership, Share Sale, Insider Selling, Grupo Angeles Servicios de Salud, Healthcare, Luxembourg

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.